Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer. Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.

Article  PubMed  Google Scholar 

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The Burden of Primary Liver Cancer and underlying etiologies from 1990 to 2015 at the Global, Regional, and National Level: results from the global burden of Disease Study 2015. JAMA Oncol. 2017;3:1683–91.

Article  PubMed  PubMed Central  Google Scholar 

Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of Hepatocellular Cancer in HCV patients treated with Direct-Acting Antiviral agents. Gastroenterology. 2017;153:996–1005e1.

Article  CAS  PubMed  Google Scholar 

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty Liver Disease demonstrates an exponential increase in burden of Disease. Hepatology. 2018;67:123–33.

Article  CAS  PubMed  Google Scholar 

Hanahan D. Hallmarks of Cancer: New dimensions. Cancer Discov. 2022;12:31–46.

Article  CAS  PubMed  Google Scholar 

Yin J, Bo WT, Sun J, Xiang X, Lang JY, Zhong JH, Li LQ. New evidence and perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol. 2017;5:169–76.

PubMed  PubMed Central  Google Scholar 

Cheng S, Chen M, Cai J, Sun J, Guo R, Bi X, Lau WY, Wu M. Chinese Expert Consensus on Multidisciplinary diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer. 2020;9:28–40.

Article  PubMed  Google Scholar 

Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998;21:386–91.

Article  CAS  PubMed  Google Scholar 

Huo L, Wei W, Yan Z, Lei Z, Xie Y, Gong R, Huang S, Jia N, Xia Y. Short-term and long-term outcomes of liver resection for HCC patients with portal vein Tumor thrombus. Cell Biosci. 2019;9:23.

Article  PubMed  PubMed Central  Google Scholar 

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65:938–43.

Article  PubMed  Google Scholar 

Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–91.

Article  CAS  PubMed  Google Scholar 

Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell. 2022;185:2390.

Article  CAS  PubMed  Google Scholar 

Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475–90.

Article  CAS  PubMed  Google Scholar 

Patop IL, Kadener S. circRNAs in Cancer. Curr Opin Genet Dev. 2018;48:121–27.

Article  CAS  PubMed  Google Scholar 

Xu L, Zhang M, Zheng X, Yi P, Lan C, Xu M. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143:17–27.

Article  PubMed  Google Scholar 

Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38:98.

Article  PubMed  PubMed Central  Google Scholar 

Hu ZQ, Zhou SL, Li J, Zhou ZJ, Wang PC, Xin HY, et al. Circular RNA sequencing identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis. Hepatology. 2020;72:906–22.

Article  CAS  PubMed  Google Scholar 

Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP. Burroughs AK A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20:325–39.

Article  PubMed  Google Scholar 

Shuqun C, Mengchao W, Han C, Feng S, Jiahe Y, Guanghui D, Wenming C, Peijun W. Yuxiang Z Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the Tumor thrombi in the portal vein. Hepatogastroenterology. 2007;54:499–502.

PubMed  Google Scholar 

Zhang H, Ye J, Weng X, Liu F, He L, Zhou D, Liu Y. Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma. Cancer Genet. 2015;208:482–91.

Article  CAS  PubMed  Google Scholar 

Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al. MicroRNA-135a contributes to the development of portal vein Tumor thrombus by promoting Metastasis in hepatocellular carcinoma. J Hepatol. 2012;56:389–96.

Article  CAS  PubMed  Google Scholar 

Yang Y, Chen L, Gu J, Zhang H, Yuan J, Lian Q, et al. Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat Commun. 2017;8:14421.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Wang P, Feng X, Tang J, Li L, Zheng X, et al. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and Metastasis of hepatocellular carcinoma. Clin Sci (Lond). 2019;133:2085–105.

Article  CAS  PubMed  Google Scholar 

Vinci M, Box C, Eccles SA. Three-dimensional (3D) Tumor spheroid invasion assay. J Vis Exp. 2015;e52686.

Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional Tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ivascu A, Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen. 2006;11:922–32.

Article  CAS  PubMed  Google Scholar 

Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125–34.

Article  CAS  PubMed  Google Scholar 

Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55–66.

Article  CAS  PubMed  Google Scholar 

Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10:170–7.

Article  CAS  PubMed  Google Scholar 

Doke AA, Jha SK, Shapeshifter. TDP-43: molecular mechanism of structural polymorphism, aggregation, phase separation and their modulators. Biophys Chem. 2023;295:106972.

Article  CAS  PubMed  Google Scholar 

Park YY, Kim SB, Han HD, Sohn BH, Kim JH, Liang J, et al. Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. Hepatology. 2013;58:182–91.

Article  CAS  PubMed  Google Scholar 

Guo F, Wang H, Jiang M, Yang Q, Xiang Q, Zhou H, et al. TDP-43 induces EMT and promotes hepatocellular carcinoma Metastasis via activating Wnt/β-catenin signaling pathway. Am J Cancer Res. 2020;10:3285–301.

CAS  PubMed  PubMed Central  Google Scholar 

Liu BW, Wang XY, Cao JL, Chen LL, Wang YL, Zhao BQ, Zhou J. Shen ZF TDP-43 upregulates lipid metabolism modulator ABHD2 to suppress apoptosis in hepatocellular carcinoma. Commun Biol. 2022;5:816.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cochran BJ, Gunawardhana LP, Vine KL, Lee JA, Lobov S, Ranson M. The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity. BMC Biotechnol. 2009;9:43.

Article  PubMed  PubMed Central  Google Scholar 

Croucher DR, Saunders DN, Lobov S, Ranson M. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer. 2008;8:535–45.

Article  CAS  PubMed  Google Scholar 

Su SC, Lin CW, Yang WE, Fan WL, Yang SF. The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets. 2016;20:551–66.

Article  CAS  PubMed  Google Scholar